SCHEMBL26795202

SCHEMBL26795202

O=c1c2cc(F)c(-c3cnc(C4CC4)cn3)cc2ccn1CC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE1C Q14123 6/20 0.42
▸ PDE1A P54750 4/20 0.42
▸ PDE1B Q01064 4/20 0.42
▸ GRM4 Q14833 1/20 0.37
▸ KIT P10721 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ FEN1 P39748 6/20 0.33
▸ ALOX5AP P20292 5/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GRIN1 Q05586 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ GRIN2B Q13224 1/20 0.33
▸ GRM2 Q14416 2/20 0.33
▸ PDE4A P27815 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ PSMB5 P28074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26795358 0.84 PDE1C (0.38) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26795404 0.79 KDM1A (0.34) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26795337 0.78 PDE4A (0.35) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26800672 0.78 GRM4 (0.35) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26800619 0.78 PSMB5 (0.38) PDE1CPDE1APDE1BGRM4FLT3
SCHEMBL26804099 0.76 TIPARP (0.38) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26804054 0.76 PDE1C (0.36) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26795283 0.76 GRM4 (0.34) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26795228 0.75 GRM4 (0.38) PDE1CPDE1APDE1BGRM4KIT
SCHEMBL26800602 0.75 PDE4A (0.34) PDE1CPDE1APDE1BGRM4KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365529-A1 PARP7 INHIBITORS PARP1, PARP11, PARP2 PDE1C 3801/4885PDE1A 3082/4885PDE1B 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback